Martin, M., Brase, J., Ruiz, A., Prat, A., Kronenwett, R., Calvo, L., . . . Rodriguez-Lescure, A. (2016). Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study.
Citación estilo ChicagoMartin, M., et al. Prognostic Ability of EndoPredict Compared to Research-based Versions of the PAM50 Risk of Recurrence (ROR) Scores in Node-positive, Estrogen Receptor-positive, and HER2-negative Breast Cancer. A GEICAM/9906 Sub-study. 2016.
Cita MLAMartin, M., et al. Prognostic Ability of EndoPredict Compared to Research-based Versions of the PAM50 Risk of Recurrence (ROR) Scores in Node-positive, Estrogen Receptor-positive, and HER2-negative Breast Cancer. A GEICAM/9906 Sub-study. 2016.